ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO247

Omega-3 Fatty Acids Attenuate Cisplatin Nephrotoxicity via Enhancement of Autophagy Flux

Session Information

Category: Acute Kidney Injury

  • 001 AKI: Basic

Authors

  • Ham, Youngrok, Chungnam National University , Daejeon, Korea (the Republic of)
  • Jeong, Jin young, Chungnam National University, Daejeon, Korea (the Republic of)
  • Bae, Hong jin, Chungnam National University , Daejeon, Korea (the Republic of)
  • Song, Chang hun, Chungnam National University , Daejeon, Korea (the Republic of)
  • Na, Kiryang, Chungnam national university, Deajeon, Korea (the Republic of)
  • Lee, Kang Wook, Chungnam National University , Daejeon, Korea (the Republic of)
  • Kim, Jwajin, Chungnam national university, Deajeon, Korea (the Republic of)
  • Lee, Jiwon M., Chungnam National University, Daejeon, Korea (the Republic of)
  • Choi, Dae Eun, Chungnam National University , Daejeon, Korea (the Republic of)
Background

Various studies demonstrated that omega-3 polyunsaturated fatty acids (PUFAs) attenuate kidney injuries through anti-apoptotic and antioxidant properties. Recently, several studies showed that omega-3 PUFAs enhance induction of autophagy. We evaluated whether administration ω-3 PUFAs may induce autophagy in cisplatin nephrotoxicity, and investigated the role of autophagy in attenuating cisplatin nephrotoxicity by ω-3 PUFAs.

Methods

10-week- old male C57BL/6 mice were divided into 4 groups; control, control plus omega 3, cisplatin, cisplatin plus omega 3; they were injected with a vehicle or single dose of cisplatin (16 mg/kg body weight) intraperitoneally. Omega 3 and vehicle were administered orally using an NG tube (Omega 32,000 μg/kg/day) from pre-injection day to 3 days after injection of cisplatin. Mice were sacrificed at 4 days after administration of cisplatin and kidney tissue were collected. Real time PCR, western blot and immunohistochemistry for molecular study and H&E stain and PAS stain for histologic examination were performed.

Results

Omega 3 treated cisplatin-mice showed improvement of renal cell survival, renal function,and pathologic damage compared to vehicle treated cisplatin-mice. Omega-3 treatment also reduced the renal expression of MCP-1 (Monocytye chemotactic protein-1) and OPN (Osteopontin) in cisplatin-treated kidney. Cisplatin-mice kidney showed that higher amounts of LC3, Beclin-1 and p62 compared to sham mice. Omega 3 treated cisplatin kidney showed higher amounts of LC3 and Beclin-1 and lower amounts of p62 compared to vehicle treated cisplatin kidney. Moreover, renal cathepsin D and ATP6E were also increased in omega 3 treated cisplatin-mice compared to vehicle treated cisplatin-mice.

Conclusion

Omega 3 fatty acids attenuate renal injury in cisplatin nephrotoxicity through stimulating autophagy flux